Clinical trials waiver in India-some considerations
Indian J Pharmacol
.
2018 Mar-Apr;50(2):97.
doi: 10.4103/ijp.IJP_540_17.
Authors
Atul Juneja
1
,
Tulsi Adhikari
1
Affiliation
1
National Institute of Medical Statistics, ICMR, New Delhi, India.
PMID:
30100660
PMCID:
PMC6044129
DOI:
10.4103/ijp.IJP_540_17
No abstract available
Publication types
Letter
MeSH terms
Clinical Trials as Topic*
Developed Countries
Drug Approval*
Humans
India